DermTech, Inc.

Symbol: DMTK

NASDAQ

0.6906

USD

Market price today

  • -0.2126

    P/E Ratio

  • 0.0002

    PEG Ratio

  • 23.91M

    MRK Cap

  • 0.00%

    DIV Yield

DermTech, Inc. (DMTK) Financial Statements

On the chart you can see the default numbers in dynamics for DermTech, Inc. (DMTK). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of DermTech, Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

balance-sheet.row.cash-and-short-term-investments

055.9126.2225.3
63.8
15.4
0.4
0
0

balance-sheet.row.short-term-investments

019.148.448.4
39.5
12.4
146.4
0
0

balance-sheet.row.net-receivables

02.64.23.8
1.5
0.7
0
0
0

balance-sheet.row.inventory

011.80.5
0.1
0
0
0
0

balance-sheet.row.other-current-assets

02.33.93.2
1.5
1.1
0.1
0
0

balance-sheet.row.total-current-assets

061.8136232.8
66.9
17.1
0.5
0
0

balance-sheet.row.property-plant-equipment-net

056.762.412.3
2.7
1
0
0
0

balance-sheet.row.goodwill

0000
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0000
0
0
0
0
0

balance-sheet.row.long-term-investments

03.53.53
0
0
146.4
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0

balance-sheet.row.other-non-current-assets

000.20.2
0.2
0.1
0
0.2
0.1

balance-sheet.row.total-non-current-assets

060.26615.5
2.9
1.1
146.4
0.2
0.1

balance-sheet.row.other-assets

0000
0
0
0
0
0

balance-sheet.row.total-assets

0121.9202.1248.3
69.8
18.2
146.9
0.2
0.2

balance-sheet.row.account-payables

01.52.42.9
1.6
1.6
0
0
0

balance-sheet.row.short-term-debt

03.11.81.6
0.1
0
0
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0

balance-sheet.row.long-term-debt-total

051.354.16.3
0.2
0
0
0
0

Deferred Revenue Non Current

0000
0.6
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-

balance-sheet.row.other-current-liab

08.711.46.3
2.8
2.7
0
0.2
0.1

balance-sheet.row.total-non-current-liabilities

051.354.16.4
0.9
5
5
0
0

balance-sheet.row.other-liabilities

0000
0
-5
0
0
0

balance-sheet.row.capital-lease-obligations

051.355.87.9
0.3
0
0
0
0

balance-sheet.row.total-liab

064.869.718.6
6.3
5.7
5.1
0.2
0.1

balance-sheet.row.preferred-stock

0000
69.8
0
0
0
0

balance-sheet.row.common-stock

0000
0
0
141
0
0

balance-sheet.row.retained-earnings

0-423.9-323-206.4
-126.4
-91.1
0.9
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.2-0.8-0.1
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0480.9456.2436.2
120.1
103.6
0
0
0

balance-sheet.row.total-stockholders-equity

057.2132.4229.7
63.5
12.5
141.8
0
0

balance-sheet.row.total-liabilities-and-stockholders-equity

0121.9202.1248.3
69.8
18.2
146.9
0.2
0.2

balance-sheet.row.minority-interest

0000
0
0
0
0
0

balance-sheet.row.total-equity

057.2132.4229.7
63.5
12.5
141.8
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-

Total Investments

022.648.448.4
39.5
12.4
146.4
0
0

balance-sheet.row.total-debt

054.455.87.9
0.3
0
0
0
0

balance-sheet.row.net-debt

017.7-21.9-169
-23.9
-15.4
-0.4
0
0

Cash Flow Statement

The financial landscape of DermTech, Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017

cash-flows.row.net-income

0-100.9-116.7-78.3
-35.2
-19.7
0.9
0

cash-flows.row.depreciation-and-amortization

05.84.52.3
0.5
0.1
0
0

cash-flows.row.deferred-income-tax

0-29.800
0
-0.6
0
0

cash-flows.row.stock-based-compensation

018.618.913.3
5
1.3
0
0

cash-flows.row.change-in-working-capital

00-2.6-1.2
1.1
0.7
-0.1
0

cash-flows.row.account-receivables

01.6-0.3-2.4
-0.8
-0.1
0
0

cash-flows.row.inventory

00.8-1.3-0.4
-0.1
0
0
0

cash-flows.row.account-payables

0-1.81.94.3
0.8
1.3
0
0

cash-flows.row.other-working-capital

0-0.5-2.8-2.8
1.2
-0.6
-0.1
0

cash-flows.row.other-non-cash-items

029.30.61.9
0
0.4
-1.2
0

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-0.9-3.3-2.7
-1.8
-0.2
0
0

cash-flows.row.acquisitions-net

01-0.7-0.1
39.5
0
0
0

cash-flows.row.purchases-of-investments

0-34.4-31.5-48.1
-41.7
0
-145.2
0

cash-flows.row.sales-maturities-of-investments

065.230.538.3
2.2
0
0
0

cash-flows.row.other-investing-activites

0-10.70.1
-39.5
0
0
0

cash-flows.row.net-cash-used-for-investing-activites

029.9-4.3-12.5
-41.3
-0.2
-145.2
0

cash-flows.row.debt-repayment

0-0.1-0.1-0.2
0
-0.5
0
0

cash-flows.row.common-stock-issued

06.20158.4
43
19.8
146.5
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0

cash-flows.row.other-financing-activites

00.9172
35.9
9.3
-0.5
0

cash-flows.row.net-cash-used-provided-by-financing-activities

06.10.9230.3
78.9
28.6
146
0

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0

cash-flows.row.net-change-in-cash

0-41-98.7155.7
8.9
10.6
0.4
0

cash-flows.row.cash-at-end-of-period

036.781.2179.9
24.2
15.4
0.4
0

cash-flows.row.cash-at-beginning-of-period

077.8179.924.2
15.4
4.8
0
0

cash-flows.row.operating-cash-flow

0-77-95.3-62.1
-28.7
-17.8
-0.4
0

cash-flows.row.capital-expenditure

0-0.9-3.3-2.7
-1.8
-0.2
0
0

cash-flows.row.free-cash-flow

0-77.9-98.6-64.8
-30.5
-18
-0.4
0

Income Statement Row

DermTech, Inc.'s revenue saw a change of NaN% compared with the previous period. The gross profit of DMTK is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017

income-statement-row.row.total-revenue

015.314.511.8
5.9
3.4
0
0

income-statement-row.row.cost-of-revenue

01513.910.6
6
3.3
0.3
0

income-statement-row.row.gross-profit

00.30.61.3
-0.1
0.1
-0.3
0

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.other-expenses

0000
0
-0.4
0.3
0

income-statement-row.row.operating-expenses

0104118.878.7
35.2
17.7
0.3
0

income-statement-row.row.cost-and-expenses

0119132.789.2
41.2
21
0.3
0

income-statement-row.row.interest-income

02.81.30.2
0
0
1.2
0

income-statement-row.row.interest-expense

001.30
0
2.7
-1.2
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-

income-statement-row.row.total-other-income-expensenet

02.91.5-0.9
0
-2.1
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
0
-0.4
0.3
0

income-statement-row.row.total-operating-expenses

02.91.5-0.9
0
-2.1
0
0

income-statement-row.row.interest-expense

001.30
0
2.7
-1.2
0

income-statement-row.row.depreciation-and-amortization

05.8-0.11.1
0.5
-0.4
0
0

income-statement-row.row.ebitda-caps

0---
-
-
-
-

income-statement-row.row.operating-income

0-103.7-118.2-77.4
-35.3
-17.6
-0.3
0

income-statement-row.row.income-before-tax

0-100.9-116.7-78.3
-35.2
-19.7
0.9
0

income-statement-row.row.income-tax-expense

00-3-1.4
-0.5
2.2
-1.2
0

income-statement-row.row.net-income

0-100.9-113.7-77
-34.7
-21.9
0.9
0

Frequently Asked Question

What is DermTech, Inc. (DMTK) total assets?

DermTech, Inc. (DMTK) total assets is 121930000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.018.

What is company free cash flow?

The free cash flow is -2.269.

What is enterprise net profit margin?

The net profit margin is -6.545.

What is firm total revenue?

The total revenue is -6.782.

What is DermTech, Inc. (DMTK) net profit (net income)?

The net profit (net income) is -100888000.000.

What is firm total debt?

The total debt is 54394000.000.

What is operating expences number?

The operating expences are 104015000.000.

What is company cash figure?

Enretprise cash is 0.000.